Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Return on Capital Employed: 2018-2020

Historic Return on Capital Employed for Cogent Biosciences (COGT) over the last 3 years, with Dec 2020 value amounting to -0.45%.

  • Cogent Biosciences' Return on Capital Employed rose 35.00% to -0.45% in Q4 2020 from the same period last year, while for Dec 2020 it was -0.45%, marking a year-over-year increase of 35.00%. This contributed to the annual value of -0.60% for FY2020, which is 1.00% down from last year.
  • According to the latest figures from Q4 2020, Cogent Biosciences' Return on Capital Employed is -0.45%, which was up 56.99% from -1.05% recorded in Q3 2020.
  • Over the past 5 years, Cogent Biosciences' Return on Capital Employed peaked at -0.45% during Q4 2020, and registered a low of -1.16% during Q1 2018.
  • For the 3-year period, Cogent Biosciences' Return on Capital Employed averaged around -0.78%, with its median value being -0.78% (2019).
  • Over the last 5 years, Cogent Biosciences' Return on Capital Employed had its largest YoY gain of 45bps in 2019, and its largest YoY loss of 64bps in 2019.
  • Cogent Biosciences' Return on Capital Employed (Quarterly) stood at -0.55% in 2018, then declined by 25bps to -0.80% in 2019, then spiked by 35bps to -0.45% in 2020.
  • Its last three reported values are -0.45% in Q4 2020, -1.05% for Q3 2020, and -0.87% during Q2 2020.